Repository logo
 
Publication

Assessing the vaccine effectiveness of seasonal influenza vaccines: a systematic review and meta-analysis of randomized controlled trials and observational studies

dc.contributor.authorMartins, André
dc.contributor.authorSantos, Marlene
dc.contributor.authorMartins, João
dc.date.accessioned2023-09-21T16:46:19Z
dc.date.available2023-09-21T16:46:19Z
dc.date.issued2023-07-11
dc.description.abstractInfluenza is a respiratory disease caused by the highly transmissible influenza virus in humans. Vaccination is a crucial strategy for preventing influenza and its associated complications. This paper aims to provide a comprehensive assessment of the vaccine effectiveness (VE) of seasonal influenza vaccines (SIVs) in individuals aged 15 to 64 years through a systematic review and meta-analysis of randomized controlled trials (RCTs) and observational studies (TNDs). A systematic review with meta-analysis was performed to identify all relevant studies that examined the effectiveness of SIVs. The primary outcome measure of interest was the VE against laboratory-confirmed influenza, regardless of the viral strain. To evaluate the quality of the included studies, the researchers utilized the Cochrane risk-of-bias tool for RCTs and the ROBINS-I tool for TNDs, which assessed the methodological quality and potential biases in study design, conduct, and analysis. The search process yielded a total of 2993 records, and after a thorough evaluation, 125 studies from 73 papers met the inclusion criteria and were included in the meta-analysis. Among the included studies, 9 were RCTs, which provide a higher level of evidence, and 116 were TNDs, which offer valuable real-world data. The pooled VE estimate for RCTs was determined to be 48% with a 95% confidence interval (CI) ranging from 42% to 54%. This finding indicates that, on average, SIVs reduced the risk of laboratory-confirmed influenza by 48% among individuals aged 15 to 64 years in the RCTs. For the TNDs, the adjusted VE estimate was found to be 39.9% with a 95% CI of 31% to 48%. Adjusted VE accounts for potential confounding factors that may influence the vaccine's effectiveness, such as age, comorbidities, and other variables. Additionally, the non-adjusted VE estimate for TNDs was 41% with a 95% CI of 37% to 45%. The key factor influencing VE is the match between the influenza strains included in the vaccine and the strains currently circulating in the population. A high level of strain match enhances the effectiveness of SIVs in preventing laboratory-confirmed influenza cases. These findings highlight the importance of ongoing surveillance and timely updates of the vaccine composition to ensure optimal protection against the circulating influenza strains.pt_PT
dc.description.versioninfo:eu-repo/semantics/publishedVersionpt_PT
dc.identifier.citationMartins, A., Santos, M., & Martins, J. (2023). Assessing the vaccine effectiveness of seasonal Influenza vaccines: A systematic review and meta-analysis of randomized controlled trials and observational studies. Proceedings of Research and Practice in Allied and Environmental Health, 1(1), 25. https://doi.org/10.26537/prpaeh.v1i1.5167pt_PT
dc.identifier.doi10.26537/prpaeh.v1i1.5167pt_PT
dc.identifier.urihttp://hdl.handle.net/10400.22/23594
dc.language.isoengpt_PT
dc.relation.publisherversionhttps://parc.ipp.pt/index.php/PRPAEH/article/view/5167pt_PT
dc.subjectInfluenzapt_PT
dc.subjectObservational studiespt_PT
dc.subjectRandomized controlled trialspt_PT
dc.subjectSeasonal influenza vaccinespt_PT
dc.subjectVaccine effectivenesspt_PT
dc.titleAssessing the vaccine effectiveness of seasonal influenza vaccines: a systematic review and meta-analysis of randomized controlled trials and observational studiespt_PT
dc.typeconference object
dspace.entity.typePublication
oaire.citation.startPage25pt_PT
oaire.citation.titleProceedings of Research and Practice in Allied and Environmental Health 2023pt_PT
oaire.citation.volume1 (1)pt_PT
person.familyNameSantos
person.givenNameMarlene
person.identifier1508370
person.identifier.ciencia-id8311-B967-31C4
person.identifier.orcid0000-0001-5020-5942
person.identifier.scopus-author-id57110502000
rcaap.rightsopenAccesspt_PT
rcaap.typeconferenceObjectpt_PT
relation.isAuthorOfPublication8ce9ee39-a4c6-46ae-99e2-49397b550f1b
relation.isAuthorOfPublication.latestForDiscovery8ce9ee39-a4c6-46ae-99e2-49397b550f1b

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
COM_Marlene Santos 2.pdf
Size:
144.04 KB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: